Producer

Tasmanian Alkaloids Pty Ltd

HQ AU · Tasmaniawebsite ↗

Tasmanian Alkaloids Pty Ltd (Westbury, Tasmania, Australia) is the world's single largest producer of pharmaceutical thebaine and oripavine — accounting for approximately 45-50% of global supply. Operating since the 1960s on Tasmania's north-west agricultural belt, the company contracts with hundreds of Tasmanian poppy farmers who cultivate high-thebaine Papaver somniferum and Papaver bracteatum varieties. Tasmania's combination of cool temperate climate, long daylight hours, and well-drained basaltic soils creates uniquely favorable conditions for alkaloid accumulation in the poppy capsule that are extremely difficult to replicate elsewhere. Owned by Johnson Matthey from 2003 until 2022, when JM's pharmaceutical API division (including Tasmanian Alkaloids) was divested to Noramco Inc. and its private equity owner IAT (Investissement Atypique Therapeutique). Tasmanian Alkaloids processes raw poppy straw on-site into crude alkaloid concentrates, which are then shipped to Noramco's US processing facility in Wilmington, Delaware for further purification into pharmaceutical-grade APIs for oxycodone, hydrocodone, naloxone, and naltrexone. The entire Tasmanian operation — cultivation, harvest, and initial alkaloid extraction — operates under strict INCB (International Narcotics Control Board) quota allocation and Australian Federal Police oversight.

1

Inputs supplied

1

Goods downstream

2

Facilities

1

Stories

What they make

1 input Tasmanian Alkaloids Pty Ltd supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Tasmanian Alkaloids Pty Ltd makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Thebaine Production (Opioid Painkiller Precursor)

    55%
  • Oripavine Production (Addiction Treatment Precursor)

    35%
  • Poppy Agricultural Operations

    10%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Did you know2023

    Tasmanian Alkaloids' poppies produce both: (1) thebaine, the precursor for oxycodone and oxymorphone — the painkillers at the center of the US opioid epidemic that has killed ~500,000 Americans since 1999; and (2) oripavine, the precursor for buprenorphine (Suboxone) and naloxone (Narcan) — the medications used to treat opioid addiction and reverse opioid overdose. The same Tasmanian paddock that provides the chemical inputs for the pharmaceutical supply chains enabling opioid addiction simultaneously provides the chemical inputs for the treatment supply chains treating that addiction. The crisis and the cure are grown in the same Tasmanian soil and processed in the same Westbury facility — the supply chain connection between an epidemic and its antidote runs through one Tasmanian alkaloid producer.

    International Narcotics Control Board
  • Origin2023

    Tasmanian Alkaloids was established in the 1960s after Australia was granted a licensed pharmaceutical poppy cultivation quota under the International Narcotics Control Board framework. Tasmania's cool, maritime climate — moderated by the Roaring Forties westerlies — proved ideal for cultivating high-thebaine poppy varieties developed by government agricultural programs. The Australian government and the INCB specifically designated Tasmania (rather than mainland Australia) due to its island geography, which helps physically contain poppy cultivation and simplifies monitoring. Today, from a tiny island with ~540,000 people, Tasmanian Alkaloids controls nearly half of the global supply of two of the most critical opioid alkaloid precursors.

    Tasmanian Alkaloids Pty Ltd